Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 4620 | 24.205 |
09:34 ET | 1150 | 24.25 |
09:36 ET | 5212 | 24.22 |
09:39 ET | 500 | 24.205 |
09:41 ET | 1009 | 24.215 |
09:43 ET | 1692 | 24.25 |
09:45 ET | 366 | 24.2 |
09:48 ET | 1112 | 24.27 |
09:50 ET | 1114 | 24.26 |
09:52 ET | 500 | 24.26 |
09:54 ET | 1717 | 24.26 |
09:56 ET | 500 | 24.24 |
09:57 ET | 2145 | 24.27 |
09:59 ET | 400 | 24.23 |
10:01 ET | 751 | 24.2 |
10:03 ET | 2900 | 24.2101 |
10:06 ET | 6500 | 24.29 |
10:08 ET | 1726 | 24.27 |
10:10 ET | 806 | 24.23 |
10:12 ET | 4125 | 24.23 |
10:14 ET | 58206 | 24.22 |
10:15 ET | 42257 | 24.19 |
10:17 ET | 2670 | 24.22 |
10:21 ET | 4478 | 24.19 |
10:24 ET | 1832 | 24.21 |
10:26 ET | 3260 | 24.205 |
10:28 ET | 9259 | 24.19 |
10:30 ET | 3884 | 24.19 |
10:32 ET | 3658 | 24.165 |
10:33 ET | 100 | 24.17 |
10:35 ET | 1176 | 24.18 |
10:37 ET | 2460 | 24.16 |
10:39 ET | 400 | 24.18 |
10:42 ET | 4000 | 24.16 |
10:44 ET | 900 | 24.15 |
10:46 ET | 1178 | 24.1202 |
10:48 ET | 2175 | 24.13 |
10:50 ET | 1400 | 24.14 |
10:53 ET | 1288 | 24.13 |
10:55 ET | 701 | 24.14 |
10:57 ET | 500 | 24.145 |
11:00 ET | 1600 | 24.155 |
11:02 ET | 2450 | 24.155 |
11:04 ET | 1750 | 24.16 |
11:06 ET | 1294 | 24.16 |
11:08 ET | 2332 | 24.16 |
11:09 ET | 100 | 24.16 |
11:11 ET | 700 | 24.165 |
11:13 ET | 900 | 24.165 |
11:15 ET | 3019 | 24.1827 |
11:18 ET | 1200 | 24.19 |
11:20 ET | 400 | 24.195 |
11:24 ET | 900 | 24.195 |
11:26 ET | 3508 | 24.17 |
11:27 ET | 400 | 24.17 |
11:29 ET | 350 | 24.17 |
11:31 ET | 200 | 24.16 |
11:33 ET | 8034 | 24.19 |
11:36 ET | 500 | 24.19 |
11:38 ET | 1410 | 24.195 |
11:40 ET | 400 | 24.2 |
11:42 ET | 1722 | 24.19 |
11:45 ET | 2774 | 24.185 |
11:47 ET | 100 | 24.2 |
11:49 ET | 14701 | 24.18 |
11:51 ET | 200 | 24.185 |
11:54 ET | 1947 | 24.19 |
11:56 ET | 70460 | 24.25 |
11:58 ET | 4015 | 24.24 |
12:00 ET | 603 | 24.25 |
12:02 ET | 11200 | 24.31 |
12:03 ET | 9489 | 24.28 |
12:05 ET | 4550 | 24.33 |
12:07 ET | 2449 | 24.35 |
12:09 ET | 1498 | 24.37 |
12:12 ET | 4615 | 24.42 |
12:14 ET | 70726 | 24.48 |
12:16 ET | 6620 | 24.42 |
12:18 ET | 1500 | 24.47 |
12:20 ET | 4598 | 24.46 |
12:21 ET | 1400 | 24.46 |
12:23 ET | 10354 | 24.435 |
12:25 ET | 2400 | 24.43 |
12:27 ET | 3149 | 24.395 |
12:30 ET | 530 | 24.4 |
12:32 ET | 500 | 24.41 |
12:34 ET | 300 | 24.405 |
12:36 ET | 4425 | 24.35 |
12:38 ET | 400 | 24.37 |
12:39 ET | 300 | 24.375 |
12:41 ET | 1420 | 24.37 |
12:43 ET | 1000 | 24.38 |
12:45 ET | 500 | 24.375 |
12:48 ET | 700 | 24.38 |
12:50 ET | 1900 | 24.36 |
12:52 ET | 51362 | 24.39 |
12:54 ET | 3350 | 24.375 |
12:56 ET | 3863 | 24.39 |
12:57 ET | 1049 | 24.38 |
12:59 ET | 100 | 24.385 |
01:03 ET | 3050 | 24.38 |
01:06 ET | 938 | 24.39 |
01:08 ET | 955 | 24.38 |
01:10 ET | 1850 | 24.397 |
01:12 ET | 2939 | 24.42 |
01:14 ET | 843 | 24.42 |
01:15 ET | 200 | 24.44 |
01:17 ET | 2500 | 24.41 |
01:21 ET | 100 | 24.41 |
01:24 ET | 601 | 24.405 |
01:26 ET | 1591 | 24.405 |
01:28 ET | 2179 | 24.39 |
01:30 ET | 2400 | 24.4 |
01:32 ET | 596 | 24.395 |
01:33 ET | 200 | 24.395 |
01:35 ET | 3952 | 24.38 |
01:37 ET | 200 | 24.38 |
01:39 ET | 300 | 24.375 |
01:42 ET | 1277 | 24.365 |
01:44 ET | 2167 | 24.385 |
01:46 ET | 200 | 24.385 |
01:48 ET | 338 | 24.3801 |
01:50 ET | 1700 | 24.385 |
01:51 ET | 1004 | 24.39 |
01:53 ET | 3918 | 24.395 |
01:55 ET | 800 | 24.3924 |
01:57 ET | 55705 | 24.38 |
02:00 ET | 100 | 24.36 |
02:02 ET | 300 | 24.35 |
02:04 ET | 1068 | 24.34 |
02:06 ET | 300 | 24.345 |
02:08 ET | 300 | 24.34 |
02:09 ET | 9526 | 24.36 |
02:11 ET | 600 | 24.38 |
02:13 ET | 2631 | 24.39 |
02:15 ET | 1200 | 24.365 |
02:18 ET | 300 | 24.375 |
02:20 ET | 1789 | 24.38 |
02:22 ET | 400 | 24.3799 |
02:24 ET | 2278 | 24.38 |
02:26 ET | 1211 | 24.38 |
02:27 ET | 100 | 24.375 |
02:29 ET | 2400 | 24.3706 |
02:31 ET | 100 | 24.375 |
02:33 ET | 1700 | 24.38 |
02:36 ET | 1692 | 24.37 |
02:38 ET | 2945 | 24.37 |
02:40 ET | 1800 | 24.385 |
02:42 ET | 3602 | 24.38 |
02:44 ET | 1303 | 24.36 |
02:45 ET | 1100 | 24.38 |
02:47 ET | 2504 | 24.36 |
02:49 ET | 895 | 24.36 |
02:51 ET | 200 | 24.365 |
02:54 ET | 1844 | 24.375 |
02:56 ET | 3016 | 24.36 |
02:58 ET | 54675 | 24.45 |
03:00 ET | 5375 | 24.465 |
03:02 ET | 5322 | 24.455 |
03:03 ET | 2250 | 24.415 |
03:05 ET | 2129 | 24.43 |
03:07 ET | 800 | 24.44 |
03:09 ET | 3065 | 24.4241 |
03:12 ET | 3059 | 24.43 |
03:14 ET | 615 | 24.435 |
03:16 ET | 100 | 24.435 |
03:18 ET | 7099 | 24.44 |
03:20 ET | 900 | 24.4242 |
03:21 ET | 54800 | 24.449 |
03:23 ET | 811 | 24.44 |
03:25 ET | 4907 | 24.485 |
03:27 ET | 400 | 24.49 |
03:30 ET | 3015 | 24.46 |
03:32 ET | 2301 | 24.44 |
03:34 ET | 3442 | 24.435 |
03:36 ET | 4982 | 24.405 |
03:38 ET | 2335 | 24.385 |
03:39 ET | 1883 | 24.4 |
03:41 ET | 7243 | 24.365 |
03:43 ET | 7565 | 24.375 |
03:45 ET | 4742 | 24.395 |
03:48 ET | 22892 | 24.39 |
03:50 ET | 5444 | 24.415 |
03:52 ET | 77866 | 24.41 |
03:54 ET | 8546 | 24.405 |
03:56 ET | 25717 | 24.345 |
03:57 ET | 16469 | 24.365 |
03:59 ET | 343458 | 24.38 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.1B | 7.0x | --- |
Exelixis Inc | 6.1B | 32.6x | -21.77% |
PTC Therapeutics Inc | 2.5B | -5.2x | --- |
P3 Health Partners Inc | 191.1M | -0.9x | --- |
Novavax Inc | 1.8B | -4.7x | --- |
Halozyme Therapeutics Inc | 5.7B | 18.6x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.45 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 7.0x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.2x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.